Divi's Laboratories, 532488, DIVISLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

98,972.00
33.43
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

96,153.12
0.80%
8.44

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.37
18.15
18.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.88
25.18
16.31

PAT CAGR (%)

10 Years
5 Years
3 Years

17.27
27.55
29.08

P:E (Median)

8 Years
5 Years
3 Years

33.49
44.45
49.26

P:BV (Average)

8 Years
5 Years
3 Years

7.82
8.43
10.10

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.44
28.93
32.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 2,203.92 1,950.16 13.01% 2,495.03 1,718.39 45.20% 2,466.77 1,656.48 48.92% 1,967.86 1,713.78 14.83%
Expenses 1,366.34 1,098.69 24.36% 1,399.06 1,019.04 37.29% 1,366.87 978.03 39.76% 1,149.27 981.39 17.11%
EBITDA 837.58 851.47 -1.63% 1,095.97 699.35 56.71% 1,099.90 678.45 62.12% 818.59 732.39 11.77%
EBIDTM 38.00% 43.66% 43.93% 40.70% 44.59% 40.96% 41.60% 42.74%
Other Income 89.99 35.55 153.14% 50.51 22.85 121.05% 16.62 19.68 -15.55% 19.11 13.64 40.10%
Interest 0.10 0.24 -58.33% 0.04 0.18 -77.78% 0.20 0.22 -9.09% 0.17 0.11 54.55%
Depreciation 83.42 73.01 14.26% 80.75 69.84 15.62% 79.70 67.95 17.29% 77.09 60.89 26.61%
PBT 844.05 813.77 3.72% 1,065.69 652.18 63.40% 1,036.62 629.96 64.55% 760.44 685.03 11.01%
Tax 152.44 261.80 -41.77% 182.73 164.25 11.25% 129.40 168.72 -23.30% 154.05 171.73 -10.30%
PAT 691.61 551.97 25.30% 882.96 487.93 80.96% 907.22 461.24 96.69% 606.39 513.30 18.14%
PATM 31.38% 28.30% 35.39% 28.39% 36.78% 27.84% 30.81% 29.95%
EPS 26.05 20.79 25.30% 33.26 18.38 80.96% 34.17 17.37 96.72% 22.84 19.33 18.16%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 2,254.52 1,960.64 14.99% 2,518.44 1,788.19 40.84% 2,493.24 1,701.44 46.54% 1,987.51 1,749.30 13.62%
Expenses 1,407.82 1,108.59 26.99% 1,414.02 1,071.93 31.91% 1,396.06 1,010.23 38.19% 1,169.44 1,008.16 16.00%
EBITDA 846.70 852.05 -0.63% 1,104.42 716.26 54.19% 1,097.18 691.21 58.73% 818.07 741.14 10.38%
EBIDTM 37.56% 43.46% 43.85% 40.05% 44.01% 40.63% 41.16% 42.37%
Other Income 88.39 35.97 145.73% 52.39 23.52 122.75% 16.62 19.32 -13.98% 19.11 13.64 40.10%
Interest 0.13 0.28 -53.57% 0.08 0.21 -61.90% 0.23 0.27 -14.81% 0.21 0.16 31.25%
Depreciation 83.66 73.26 14.20% 80.99 70.08 15.57% 79.91 68.18 17.20% 77.35 61.13 26.53%
PBT 851.30 814.48 4.52% 1,075.74 669.49 60.68% 1,033.66 642.08 60.99% 759.62 693.49 9.54%
Tax 149.29 257.37 -41.99% 181.10 167.47 8.14% 131.42 171.46 -23.35% 153.16 173.90 -11.93%
PAT 702.01 557.11 26.01% 894.64 502.02 78.21% 902.24 470.62 91.71% 606.46 519.59 16.72%
PATM 31.14% 28.41% 35.52% 28.07% 36.19% 27.66% 30.51% 29.70%
EPS 26.45 20.99 26.01% 33.70 18.91 78.21% 33.99 17.73 91.71% 22.85 19.57 16.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 9,133.58 8,879.82 6,798.61 5,310.57 4,879.66 3,815.94 4,023.85 3,721.33 3,084.01 2,513.97 2,128.89 Net Sales Growth 29.76% 30.61% 28.02% 8.83% 27.88% -5.17% 8.13% 20.67% 22.67% 18.09% Cost Of Goods Sold 3,140.25 2,989.80 2,265.50 2,088.56 1,837.83 1,504.90 1,541.58 1,495.70 1,215.44 918.14 797.66 Gross Profit 5,993.33 5,890.02 4,533.11 3,222.01 3,041.83 2,311.04 2,482.27 2,225.62 1,868.57 1,595.82 1,331.23 GP Margin 65.62% 66.33% 66.68% 60.67% 62.34% 60.56% 61.69% 59.81% 60.59% 63.48% 62.53% Total Expenditure 5,281.54 5,005.05 3,977.73 3,494.16 3,029.59 2,564.33 2,584.97 2,319.91 1,920.97 1,494.24 1,306.36 Power & Fuel Cost - 390.05 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.39% 4.69% 5.29% 5.10% 5.99% 4.94% 4.85% 5.54% 5.86% 6.15% Employee Cost - 926.55 808.68 608.36 530.72 446.27 490.33 352.95 283.15 225.43 191.20 % Of Sales - 10.43% 11.89% 11.46% 10.88% 11.69% 12.19% 9.48% 9.18% 8.97% 8.98% Manufacturing Exp. - 336.15 269.24 238.06 189.32 169.16 155.91 159.65 134.82 110.93 96.90 % Of Sales - 3.79% 3.96% 4.48% 3.88% 4.43% 3.87% 4.29% 4.37% 4.41% 4.55% General & Admin Exp. - 211.22 166.34 135.34 97.56 133.03 79.49 67.41 58.68 46.15 40.67 % Of Sales - 2.38% 2.45% 2.55% 2.00% 3.49% 1.98% 1.81% 1.90% 1.84% 1.91% Selling & Distn. Exp. - 107.56 110.21 75.11 62.51 58.37 59.82 50.37 45.83 39.64 47.70 % Of Sales - 1.21% 1.62% 1.41% 1.28% 1.53% 1.49% 1.35% 1.49% 1.58% 2.24% Miscellaneous Exp. - 43.72 38.61 68.00 62.87 23.87 59.04 13.48 12.23 6.55 47.70 % Of Sales - 0.49% 0.57% 1.28% 1.29% 0.63% 1.47% 0.36% 0.40% 0.26% 0.06% EBITDA 3,852.04 3,874.77 2,820.88 1,816.41 1,850.07 1,251.61 1,438.88 1,401.42 1,163.04 1,019.73 822.53 EBITDA Margin 42.17% 43.64% 41.49% 34.20% 37.91% 32.80% 35.76% 37.66% 37.71% 40.56% 38.64% Other Income 176.23 114.03 63.45 189.86 156.58 112.48 75.94 95.92 42.84 83.90 48.51 Interest 0.51 1.73 1.81 7.03 4.61 2.31 3.33 3.94 2.85 2.93 2.56 Depreciation 320.96 310.55 254.65 185.95 168.81 142.42 123.26 118.10 135.85 92.06 76.90 PBT 3,706.80 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Tax 618.62 727.98 673.15 440.58 500.58 349.78 334.96 264.45 220.12 216.92 180.16 Tax Rate 16.69% 19.80% 25.62% 24.30% 27.31% 28.69% 24.13% 19.23% 20.63% 21.51% 22.76% PAT 3,088.18 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 PAT before Minority Interest 3,088.18 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.81% 33.20% 28.75% 25.85% 27.31% 22.79% 26.18% 29.85% 27.47% 31.49% 28.72% PAT Growth 53.30% 50.84% 42.40% 3.01% 53.25% -17.44% -5.18% 31.14% 6.99% 29.49% EPS 116.32 111.06 73.62 51.70 50.19 32.75 39.67 41.84 31.90 29.82 23.03

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 9,253.71 8,959.83 6,969.40 5,394.42 4,946.26 3,891.49 4,064.34 3,776.36 3,114.94 2,532.14 2,144.84 Net Sales Growth 28.53% 28.56% 29.20% 9.06% 27.10% -4.25% 7.63% 21.23% 23.02% 18.06% Cost Of Goods Sold 3,136.96 2,967.14 2,324.08 2,108.54 1,825.22 1,534.06 1,534.00 1,505.32 1,213.24 914.15 798.63 Gross Profit 6,116.75 5,992.69 4,645.32 3,285.88 3,121.04 2,357.43 2,530.34 2,271.04 1,901.70 1,617.99 1,346.21 GP Margin 66.10% 66.88% 66.65% 60.91% 63.10% 60.58% 62.26% 60.14% 61.05% 63.90% 62.77% Total Expenditure 5,387.34 5,078.72 4,108.34 3,571.21 3,073.24 2,628.74 2,617.20 2,358.04 1,948.69 1,516.76 1,328.87 Power & Fuel Cost - 392.33 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.38% 4.58% 5.20% 5.03% 5.88% 4.89% 4.78% 5.48% 5.82% 6.11% Employee Cost - 946.16 825.76 621.05 542.27 456.06 499.90 361.19 290.42 232.46 197.72 % Of Sales - 10.56% 11.85% 11.51% 10.96% 11.72% 12.30% 9.56% 9.32% 9.18% 9.22% Manufacturing Exp. - 365.92 297.84 258.91 212.96 182.67 169.15 169.42 147.24 121.10 104.85 % Of Sales - 4.08% 4.27% 4.80% 4.31% 4.69% 4.16% 4.49% 4.73% 4.78% 4.89% General & Admin Exp. - 236.44 175.26 148.62 105.30 139.33 88.22 73.91 63.85 51.74 44.15 % Of Sales - 2.64% 2.51% 2.76% 2.13% 3.58% 2.17% 1.96% 2.05% 2.04% 2.06% Selling & Distn. Exp. - 127.01 124.03 85.36 73.08 64.02 67.48 56.04 51.93 44.22 51.29 % Of Sales - 1.42% 1.78% 1.58% 1.48% 1.65% 1.66% 1.48% 1.67% 1.75% 2.39% Miscellaneous Exp. - 43.72 42.22 68.00 65.63 23.87 59.65 11.80 11.18 5.69 51.29 % Of Sales - 0.49% 0.61% 1.26% 1.33% 0.61% 1.47% 0.31% 0.36% 0.22% 0.06% EBITDA 3,866.37 3,881.11 2,861.06 1,823.21 1,873.02 1,262.75 1,447.14 1,418.32 1,166.25 1,015.38 815.97 EBITDA Margin 41.78% 43.32% 41.05% 33.80% 37.87% 32.45% 35.61% 37.56% 37.44% 40.10% 38.04% Other Income 176.51 115.90 62.67 189.63 155.63 113.44 74.89 97.44 44.70 70.60 44.81 Interest 0.65 2.00 2.10 7.14 4.68 2.37 3.36 4.74 2.88 2.96 2.59 Depreciation 321.91 311.51 255.59 186.24 168.90 142.49 123.33 118.18 136.00 92.12 76.95 PBT 3,720.32 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Tax 614.97 723.05 681.75 442.92 502.33 354.32 334.92 267.06 220.56 217.58 179.23 Tax Rate 16.53% 19.63% 25.57% 24.34% 27.08% 28.78% 24.00% 19.17% 20.57% 21.96% 22.94% PAT 3,105.35 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 PAT before Minority Interest 3,105.35 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 33.56% 33.04% 28.47% 25.52% 27.35% 22.54% 26.09% 29.81% 27.34% 30.54% 28.07% PAT Growth 51.53% 49.19% 44.15% 1.76% 54.24% -17.30% -5.81% 32.21% 10.11% 28.46% EPS 116.96 111.50 74.74 51.85 50.95 33.03 39.94 42.40 32.07 29.13 22.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,691.35 9,271.57 7,316.69 6,973.31 5,959.65 5,408.91 4,357.04 3,561.96 3,034.42 2,553.28 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,638.26 9,218.48 7,263.60 6,920.22 5,906.56 5,355.82 4,303.95 3,535.41 3,007.87 2,526.73 Non-Current Liabilities 448.11 363.48 294.48 993.72 1,769.95 1,418.95 92.33 847.80 656.71 477.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,427.29 1,704.78 1,796.64 832.52 640.49 655.84 516.12 772.32 623.14 551.59 Trade Payables 771.30 748.78 580.34 483.31 405.65 442.30 230.42 224.38 148.69 158.31 Other Current Liabilities 392.95 337.25 286.51 242.50 170.79 176.52 239.46 202.73 146.55 129.35 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,263.04 618.40 896.16 1.11 0.94 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.27 3,581.95 Net Block 4,320.97 3,699.01 2,776.26 2,087.44 1,995.88 1,558.95 1,438.64 1,308.73 1,221.60 908.50 Gross Block 5,617.69 4,685.46 3,508.06 2,633.29 2,372.92 1,793.57 2,195.42 1,952.40 1,739.79 1,337.88 Accumulated Depreciation 1,296.72 986.45 731.80 545.85 377.04 234.62 756.78 643.67 518.19 429.38 Non Current Assets 5,011.90 4,598.63 3,852.94 4,152.06 3,816.18 3,444.55 1,907.39 2,386.10 2,034.87 1,708.04 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 79.37 7.37 7.37 554.62 7.37 8.37 10.19 2.82 2.82 2.82 Long Term Loans & Adv. 133.58 172.42 144.18 1,012.93 1,688.04 1,424.88 188.87 856.03 665.87 493.23 Other Non Current Assets 8.05 9.21 5.44 5.16 5.13 8.78 5.78 0.35 0.09 0.07 Current Assets 9,554.85 6,741.20 5,554.87 4,647.49 4,553.91 4,039.15 3,058.10 2,795.98 2,279.41 1,873.91 Current Investments 0.00 0.00 971.35 1,398.34 1,889.29 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,644.05 2,042.70 1,744.17 1,663.18 1,281.39 1,255.76 1,162.89 1,114.90 893.27 805.95 Sundry Debtors 2,569.90 1,745.56 1,533.21 1,282.24 1,112.11 1,002.89 966.12 823.03 791.64 558.90 Cash & Bank 2,803.68 2,142.01 107.36 105.20 91.48 66.47 59.38 56.66 35.77 34.68 Other Current Assets 1,537.22 51.63 48.63 11.56 179.64 83.31 66.86 68.39 56.86 66.56 Short Term Loans & Adv. 1,507.86 759.30 1,150.15 186.97 160.15 63.14 48.19 54.14 47.56 57.28 Net Current Assets 7,127.56 5,036.42 3,758.23 3,814.97 3,913.42 3,383.31 2,541.98 2,023.66 1,656.26 1,322.32 Total Assets 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.28 3,581.95

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,728.18 9,294.61 7,309.92 6,957.15 5,924.80 5,357.39 4,293.31 3,495.36 2,963.35 2,500.60 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,675.09 9,241.52 7,256.83 6,904.06 5,871.71 5,304.30 4,240.21 3,468.81 2,936.80 2,474.05 Non-Current Liabilities 436.51 363.94 294.57 991.38 1,768.91 1,411.75 85.17 841.57 650.05 469.75 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,454.44 1,728.35 1,820.53 846.75 653.42 659.45 519.50 775.53 627.41 554.45 Trade Payables 795.70 763.20 590.72 492.26 411.21 445.80 232.69 226.87 151.70 160.44 Other Current Liabilities 394.02 340.42 290.09 243.59 175.46 176.63 240.58 203.45 147.80 130.08 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,264.72 624.38 906.09 5.30 3.64 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.98 5,112.46 4,240.81 3,524.80 Net Block 4,325.05 3,703.87 2,781.85 2,087.77 1,996.19 1,559.19 1,438.77 1,308.89 1,221.84 908.72 Gross Block 5,624.27 4,691.86 3,514.25 2,633.93 2,373.45 1,793.95 2,196.08 1,953.02 1,740.34 1,338.35 Accumulated Depreciation 1,299.22 987.99 732.40 546.16 377.26 234.76 757.32 644.13 518.50 429.63 Non Current Assets 5,008.74 4,596.30 3,851.49 4,145.23 3,812.01 3,418.08 1,870.93 2,340.06 1,984.45 1,660.69 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 72.01 0.01 0.01 547.26 0.01 0.01 0.01 0.00 0.00 0.00 Long Term Loans & Adv. 133.70 172.59 144.50 1,012.93 1,688.23 1,406.48 162.44 812.63 618.03 448.49 Other Non Current Assets 8.05 9.21 5.44 5.36 7.82 8.83 5.80 0.35 0.09 0.07 Current Assets 9,610.39 6,790.60 5,573.53 4,650.05 4,535.12 4,010.51 3,027.04 2,772.40 2,256.35 1,864.11 Current Investments 0.00 0.00 971.35 1,398.34 1,889.28 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,828.62 2,145.23 1,863.86 1,772.34 1,350.67 1,319.91 1,207.83 1,162.64 932.42 835.69 Sundry Debtors 2,423.88 1,676.52 1,413.35 1,163.37 1,014.36 900.92 880.92 741.64 723.70 512.00 Cash & Bank 2,818.88 2,156.03 122.63 115.26 112.46 78.70 73.43 65.22 40.51 40.89 Other Current Assets 1,539.01 51.95 52.16 142.20 168.35 80.26 62.01 69.89 57.85 67.71 Short Term Loans & Adv. 1,509.32 760.87 1,150.18 58.54 43.37 59.59 42.88 54.98 48.16 57.97 Net Current Assets 7,155.95 5,062.25 3,753.00 3,803.30 3,881.70 3,351.06 2,507.54 1,996.87 1,628.95 1,309.66 Total Assets 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.97 5,112.46 4,240.80 3,524.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,910.16 1,947.05 1,208.47 964.06 764.72 1,149.11 1,036.34 822.44 558.15 482.83 PBT 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Adjustment 235.32 186.66 52.55 86.71 29.72 81.10 69.27 108.33 70.06 55.01 Changes in Working Capital -1,371.89 -234.52 -211.40 -472.96 -215.81 -18.52 -147.34 -141.64 -307.22 -189.31 Cash after chg. in Working capital 2,539.95 2,580.01 1,654.44 1,446.98 1,033.27 1,450.81 1,297.23 1,033.87 771.48 657.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -629.79 -632.96 -445.97 -482.92 -268.55 -301.70 -260.89 -211.43 -213.34 -174.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,195.40 75.34 -81.38 -684.24 -475.89 -1,137.41 -411.16 -520.77 -305.08 -254.49 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.86 72.32 246.93 4.58 37.22 -533.55 -45.19 -3.34 31.97 44.36 Cash from Financing Activity -531.50 -33.97 -1,091.25 -245.94 -314.17 3.27 -630.34 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -816.74 1,988.42 35.84 33.88 -25.34 14.97 -5.17 -1.28 4.57 -2.43 Opening Cash & Equivalents 2,016.30 27.88 -7.96 -41.84 -16.50 -31.47 9.06 10.35 5.78 8.20 Closing Cash & Equivalent 1,199.56 2,016.30 27.88 -7.96 -41.84 -16.50 3.89 9.06 10.35 5.78

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,911.80 1,946.93 1,215.94 954.30 775.86 1,150.37 1,037.86 826.33 556.75 479.97 PBT 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Adjustment 239.73 189.29 60.01 83.51 32.19 93.87 60.94 91.24 77.55 59.25 Changes in Working Capital -1,370.45 -264.08 -218.30 -499.84 -219.11 -37.14 -155.03 -125.55 -298.39 -186.05 Cash after chg. in Working capital 2,552.78 2,591.25 1,661.17 1,438.74 1,044.41 1,452.07 1,298.75 1,037.76 770.07 654.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -640.98 -644.32 -445.23 -484.44 -268.55 -301.70 -260.89 -211.43 -213.32 -174.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,194.92 75.13 -83.47 -685.40 -478.30 -1,139.60 -406.41 -520.84 -305.15 -254.54 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.38 72.11 244.84 3.42 34.81 -535.74 -40.44 -3.41 31.90 44.31 Cash from Financing Activity -532.44 -34.89 -1,091.42 -245.94 -314.16 2.38 -631.12 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -815.56 1,987.17 41.05 22.96 -16.60 13.15 0.33 2.54 3.10 -5.33 Opening Cash & Equivalents 2,030.32 43.15 2.10 -20.86 -4.26 -17.41 17.62 15.09 11.99 17.32 Closing Cash & Equivalent 1,214.76 2,030.32 43.15 2.10 -20.86 -4.26 17.95 17.62 15.09 11.99

Financial Ratios

Consolidated /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 440.44 349.28 275.63 262.70 224.51 203.76 164.13 134.18 114.30 96.18 ROA 22.76% 18.84% 15.08% 15.52% 10.97% 16.92% 21.89% 17.84% 20.05% 19.15% ROE 28.13% 23.57% 19.21% 20.61% 15.30% 21.57% 28.06% 25.68% 28.34% 25.86% ROCE 35.09% 31.64% 25.23% 28.06% 21.31% 28.27% 34.53% 32.22% 35.88% 32.98% Fixed Asset Turnover 1.73 1.66 1.75 1.95 1.84 2.04 1.81 1.69 1.65 1.77 Receivable days 88.26 87.73 95.70 89.55 100.59 88.38 87.08 94.72 97.33 93.02 Inventory Days 95.85 101.33 115.82 110.13 120.67 108.57 110.86 117.81 122.46 124.00 Payable days 92.79 107.07 92.94 52.95 60.35 47.52 35.14 33.59 36.19 42.55 Cash Conversion Cycle 91.32 81.99 118.58 146.72 160.91 149.43 162.79 178.93 183.60 174.46 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 2126.16 1452.86 258.94 398.66 528.86 417.89 349.89 375.24 345.75 310.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 441.82 350.15 275.38 262.09 223.20 201.82 161.73 131.67 111.63 94.20 ROA 22.77% 19.07% 15.11% 15.78% 11.12% 17.21% 22.49% 18.21% 19.92% 19.17% ROE 28.16% 23.90% 19.30% 21.00% 15.55% 21.98% 28.91% 26.37% 28.31% 25.99% ROCE 35.06% 32.07% 25.36% 28.50% 21.68% 28.75% 35.57% 33.06% 36.04% 33.21% Fixed Asset Turnover 1.74 1.70 1.77 1.98 1.88 2.06 1.83 1.70 1.66 1.78 Receivable days 83.26 80.66 86.18 80.35 89.33 79.19 77.83 85.12 88.42 85.08 Inventory Days 100.99 104.66 121.62 115.23 124.56 112.34 113.70 121.69 126.52 127.96 Payable days 95.88 106.32 93.73 52.21 60.15 47.14 35.06 33.55 36.16 42.47 Cash Conversion Cycle 88.36 79.00 114.07 143.37 153.75 144.39 156.47 173.26 178.78 170.58 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 1842.75 1270.54 255.83 397.38 520.55 416.28 294.75 373.59 336.24 302.96

Top Investors:

sbi mutual fund

axis mutual fund trustee limited

life insurance corporation of india

government pension fund global

iepf

Annual Reports:

News Update:

Divi's Laboratories reports 26% rise in Q1 consolidated net profit
12th Aug 2022, 16:53 PM

Total consolidated income of the company increased by 17.34% at Rs 2342.91 crore for Q1FY23
Read More
Divi’s Laboratories reports 78% rise in Q4 consolidated net profit
23rd May 2022, 14:38 PM

The company has reported a standalone net profit of Rs 882.96 crore for the quarter ended March 31, 2022
Read More
Divi's Lab - Quarterly Results
23rd May 2022, 12:20 PM

Read More

Divi's Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 532488 | NSE: DIVISLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Divi's Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 532488 | NSE: DIVISLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: